Zirconium-89-based PSMA PET/CT with delayed imaging for early detection of biochemical recurrence in prostate cancer patients with PSA ≤ 0.2 ng/mL: A feasibility study. - Speicher T; Latell S; Blickle A; Bastian MB; Maus S; Schaefer-Schuler A; Bartholomä M; Misirci M; Burgard C; Ezziddin S; Rosar F (European journal of nuclear medicine and molecular imaging, 2026)